Press release
Deadline on September 26th coming up in Lawsuit for Investors in Enochian Biosciences, Inc. (NASDAQ: ENOB)
A Deadline is coming up on September 26, 2022 in the lawsuit for certain investors in Enochian Biosciences, Inc. (NASDAQ: ENOB).
Investors who purchased shares of Enochian Biosciences, Inc. (NASDAQ: ENOB) have certain options and there are strict and short deadlines running. Deadline: September 26, 2022. NASDAQ: ENOB stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Central District of California the plaintiff alleges on behalf of purchasers of Enochian Biosciences, Inc. (NASDAQ: ENOB) common shares between September 24, 2020 and May 31, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between September 24, 2020 and May 31, 2022, the Defendants made false and/or misleading statements and/or failed to disclose thatGumrukcu was not a licensed doctor and had no verifiable degrees beyond high school, that accordingly, the scientific and technological underpinnings of Enochian's product pipeline, purportedly invented by Gumrukcu, were dubious at best, that accordingly, the Defendants had significantly overstated the commercial prospects for the Company's product pipeline, that Enochian's senior leadership knew Gumrukcu had a criminal history that included fraud, that accordingly, Enochian's reliance on Gumrukcu, and its consulting and licensing agreements with G-Tech and SRI, subjected the Company to a heightened risk of reputational and financial harm, as well as threatened the integrity of the Company's scientific findings, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Enochian Biosciences, Inc. (NASDAQ: ENOB) have certain options and should contact the Shareholders Foundation.
Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on September 26th coming up in Lawsuit for Investors in Enochian Biosciences, Inc. (NASDAQ: ENOB) here
News-ID: 2740472 • Views: …
More Releases from Shareholders Foundation
Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd.
Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc..
Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed…
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation.
Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open…
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced.
Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
More Releases for Enochian
Unlock the Mysteries of Forbidden Magick with New Release: Enochian Spellbook - …
Where ancient wisdom meets forbidden power. Experience the arcane mysteries of Enochian rituals and explore the perilous path of forbidden magick.
Get ready to explore the arcane with the release of Enochian Spellbook - Forbidden Archangel Magick Volume 1: 77 Forbidden Enochian Invocations, a groundbreaking grimoire authored by the distinguished scholar Liber Occultis. This highly anticipated book offers an unparalleled exploration of forbidden Enochian magick, revealing rituals and practices that challenge…
Emerging Trends and Forecast in the Dendritic Cell and Tumor Cell Cancer Vaccine …
Market Overview:
Dendritic cell and tumor cell cancer vaccines are a type of immunotherapy to treat cancer. These vaccines work by utilizing either dendritic cells or tumor cells to teach the immune system to identify and destroy cancer cells.
Market Dynamics:
The dendritic cell and tumor cell cancer vaccines market is significant growth can be attributed to two key drivers- rising prevalence of cancer worldwide and growing focus on immunotherapy for cancer treatment.…
Investigation announced for Long-Term Investors in shares of Enochian Bioscience …
An investigation was announced over possible breaches of fiduciary duties by certain directors of Enochian Biosciences, Inc.
Investors who are current long term investors in Enochian Biosciences, Inc. (NASDAQ: ENOB) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ENOB stocks follows a lawsuit filed against Enochian Biosciences, Inc.…
Lawsuit filed for Investors in shares of Enochian Biosciences, Inc. (NASDAQ: ENO …
An investor, who purchased shares of Enochian Biosciences, Inc. (NASDAQ: ENOB), filed a lawsuit over alleged violations of Federal Securities Laws by Enochian Biosciences, Inc.
Investors who purchased shares of Enochian Biosciences, Inc. (NASDAQ: ENOB) have certain options and for certain investors are short and strict deadlines running. Deadline: September 26, 2022. NASDAQ: ENOB investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Los Angeles, CA based…
Investigation announced for Investors in Enochian Biosciences, Inc. (NASDAQ: ENO …
An investigation was announced over potential securities laws violations by Enochian Biosciences, Inc. in connection with certain financial statements.
Investors who purchased shares of Enochian Biosciences, Inc. (NASDAQ: ENOB), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Enochian Biosciences, Inc. regarding its business, its prospects and its operations were…
Dendritic Cell and Tumor Cell Cancer Vaccine Market is Thriving Worldwide with T …
Dendritic Cell and Tumor Cell Cancer Vaccine market Research Report
LOS ANGELES, United States: QY Research offers an overarching research and analysis-based study on, “Global Dendritic Cell and Tumor Cell Cancer Vaccine Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application“. This report offers an insightful take on the drivers and restraints present in the market. Dendritic Cell and Tumor Cell Cancer Vaccine data…
